SOMAZINA
FERRER INTERNACIONAL S A
Identification
- Active ingredient (INN)
- CITICOLINE SOUS FORME SODIQUE
- Internal code
- 15 K 045
- Country of Origin
- Algeria
- Pharmaceutical form
- Oral Solution
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/01 flc de 30ml avec seringue doseuse
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides.
It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others.
Indications
Not Available
Mechanism of Action
Target Actions Organism U LicC protein Not Available Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4).
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.